Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Cash Flow
Glaxosmithkline Pharmaceuticals Ltd.
BSE Code 500660
ISIN Demat INE159A01016
Book Value (Rs) 98.85
NSE Code GLAXO
Dividend Yield % 1.32
Market Cap(Rs Mn) 409149.45
TTM PE(x) 61.17
TTM EPS(Rs) 39.49
Face Value (Rs) 10  
Type:
(Rs. in Million)
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax9598.038414.9424756.487230.956472.46
Adjustment-451.30-400.03-16364.84-256.41131.71
Changes In working Capital610.21-457.461198.72457.46440.68
Cash Flow after changes in Working Capital9756.957557.469590.367432.007044.85
Cash Flow from Operating Activities5820.164842.258107.485779.114905.00
Cash Flow from Investing Activities87.128078.51-4055.084180.26-568.43
Cash Flow from Financing Activities-5614.97-15433.23-5242.42-6955.60-4276.22
Net Cash Inflow / Outflow292.30-2512.46-1190.023003.7860.35
Opening Cash & Cash Equivalents349.412861.874051.891048.12987.77
Cash & Cash Equivalent on Amalgamation / Take over / Merger00000
Cash & Cash Equivalent of Subsidiaries under liquidations00000
Translation adjustment on reserves / op cash balalces frgn subsidiaries00000
Effect of Foreign Exchange Fluctuations00000
Closing Cash & Cash Equivalent641.71349.412861.874051.891048.12